Clinical Trial Update: Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

View source ↗

Summary

AstraZeneca-sponsored study in the Russian Federation assessing aggressive treatment patterns and ctDNA HRR evaluation in high-volume metastatic hormone-sensiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Status: RECRUITING